SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Denali Therapeutics Q1 EPS $(0.550) Down From $(0.410) YoY, Sales $3.604M Down From $4.205M YoY

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.550) per share. This is a 34.15 percent decrease over losses of $(0.410) per share from the same period last year. The company reported $3.604 million

Benzinga · 05/07/2020 21:31

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.550) per share. This is a 34.15 percent decrease over losses of $(0.410) per share from the same period last year. The company reported $3.604 million in sales this quarter. This is a 14.29 percent decrease over sales of $4.205 million the same period last year.